Clinical Trials Logo

Clinical Trial Summary

1. To evaluate histopathological findings of products of conception in both sporadic and recurrent miscarriage.

2. To determine the prevalence of chronic histiocytic intervillositis in both sporadic and recurrent miscarriage.


Clinical Trial Description

Early miscarriage is a term used to describe the loss of pregnancy within the first 12 weeks of gestation .This diagnosis concerns 10-15% of all pregnancies and is made based on additional tests such as serial determinations of chorionic gonadotropin concentration and imaging examinations ultrasonography. Depending on the clinical presentation and results of ultrasonography, miscarriages can be divided into complete spontaneous miscarriage, and incomplete miscarriage, when the width of the echo of residual tissues in the uterine cavity exceeds 10 mm on ultrasonography and is accompanied by the presence of clinical symptoms such as vaginal bleeding and abdominal pain .The other type of miscarriage is defined as retained products of conception (RPOC) and refers to the state when the gestational sac contains the embryo with crown-rump length (CRL) of > 7 mm but embryonic cardiac activity is invisible. Empty gestational sac is diagnosed when the gestational sac with a diameter of > 25 mm and without an embryo is visible in the uterine cavity on ultrasonography .

Histopathological examination of products of conception is an integral and a routine component of the management of patients with early pregnancy failure . Two important primary reasons for such an examination are to confirm the presence of an intrauterine gestation and to exclude gestational trophoblastic disease in the form of partial or complete hydatidiform mole . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04326595
Study type Interventional
Source Assiut University
Contact mohammed haggag hashim, resident
Phone 01065594274
Email midomido_com@yahoo.com
Status Not yet recruiting
Phase N/A
Start date December 20, 2020
Completion date May 30, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02088424 - the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION N/A
Completed NCT01612065 - Optimum Misoprostol Dose Prior to Office Hysteroscopy Phase 3
Completed NCT01051778 - Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome Phase 2
Completed NCT02457377 - Laparoscopic Transabdominal Cerclage: New Approach N/A
Completed NCT03475160 - Sildenafil Citrate and Recurrent Abortion N/A
Completed NCT01976676 - Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion Phase 2/Phase 3